Literature DB >> 8582150

Dose-ranging trials: guidelines for data collection and standardized descriptions.

J P Boissel1, I Durieu, P Girard, P Nony, F Chauvin, M Haugh.   

Abstract

Protocols for dose ranging trials in healthy volunteers or patients can be described by the combination of an experimental design and one or more decision rules. Generally, the doses are chosen on the basis of an up-and-down method, until the maximum tolerated (affecting one or more physiological parameters) and the minimum effective doses are found. Despite the large number of possible protocols there is no standard for the description of the experimental design or the decision rule(s). We propose a series of variables that can be used to facilitate data collection and that can adequately and uniquely characterize most dose ranging protocols.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582150     DOI: 10.1016/0197-2456(95)00002-x

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  1 in total

1.  Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan.

Authors:  I Nestorov; G Graham; S Duffull; L Aarons; E Fuseau; P Coates
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.